Farah Khan, MD
Psychiatry · Los Altos
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 8
- 2 carriers
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plans that list them
8 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Khan’s office at (650) 518-9255 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
8 of 8 plans
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A81188 · Current
Licensed to practise in California · since 2002 · expires 2026-11-30 · University of Karachi, Sind Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$17,542
Pharmacies billed $17,542 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 65) in 2024. At or below the middle of the specialty; the typical psychiatry & neurology clinician is at 0%.
59 generic and fewer than 11 brand-name prescriptions · $17,542 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Mirtazapine | 14 | $210 | $15 |
| Clonazepam | 15 | $106 | $7 |
Year by year
| 2024 | 65 | None | 0% (0) | None | $17,542 |
| 2023 | 49 | None | 0% (0) | 24% | $14,701 |
| 2022 | 33 | None | 0% (0) | 61% | $26,025 |
| 2021 | 24 | None | 0% (0) | None | $353 |
| 2020 | 25 | None | 0% (0) | 0% | $292 |
| 2019 | 40 | 11 | 0% (0) | 0% | $708 |
| 2018 | 16 | None | 0% (0) | 0% | $466 |
| 2017 | 28 | None | 0% (0) | None | $2,787 |
| 2015 | 15 | None | None | None | $2,882 |
| 2014 | 39 | None | None | None | $1,771 |
| 2013 | 312 | 82 | 0% (0) | 28% | $48,667 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2019: 1 drug
| Escitalopram | 13 | $82 | $6 |
2014: 1 drug
| Clopidogrel | 15 | $205 | $14 |
2013: 8 drugs
| Risperdal Consta | 22 | $12,537 | $570 |
| Abilify | 16 | $10,802 | $675 |
| Olanzapine | 12 | $3,374 | $281 |
| Risperidone | 20 | $1,034 | $52 |
| Fluoxetine | 12 | $295 | $25 |
| Lamotrigine | 19 | $224 | $12 |
| Trazodone | 31 | $169 | $5 |
| Benztropine Mesylate | 14 | $60 | $4 |
Money from drug and device companies
$61 in 2024
A payment is not proof that care is biased.
| Neurocrine Biosciences | Ingrezza | $61 | 2 payments
|
See all 2 published payments
| Neurocrine Biosciences | Meals · 2024-11-05 | Ingrezza | $33 |
| Neurocrine Biosciences | Meals · 2024-08-13 | Ingrezza | $28 |
Professional record
- NPI
- 1093778219
- Licence
- CA A81188California A81188: Current · expires 2026-11-30
More record details
- Sole proprietor
- No
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 1000 Fremont Ave, Suite 270, Los Altos, CA, 94024
- NPI first listed
- 2006-04-10
- NPI last updated
- 2013-03-05
This is when the NPI record was last certified, not a medical board exam.